Holen Sie sich die Stockscreener-App
31.90
0.01%
0.002
Handel nachbörslich:
31.82
-0.082
-0.26%
Schlusskurs vom Vortag:
$31.90
Offen:
$31.67
24-Stunden-Volumen:
7,165
Relative Volume:
0.23
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.46%
1M Leistung:
-4.47%
6M Leistung:
+12.07%
1J Leistung:
+37.87%
1-Tages-Spanne:
$31.57
$32.07
1-Wochen-Bereich:
$30.09
$32.15
52-Wochen-Spanne:
$20.01
$37.15
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Firmenname
Roundhill Glp 1 Weight Loss Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
31.90 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
655.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
658.96 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
264.66 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
584.98 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Aktie (OZEM) Neueste Nachrichten
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Trump 'Amplified' Several Investing Themes, Says ETF CEO - National Today
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Finanzdaten der Roundhill Glp 1 Weight Loss Etf-Aktie (OZEM)
Es liegen keine Finanzdaten für Roundhill Glp 1 Weight Loss Etf (OZEM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
0.62%
Kapitalisierung:
|
Volumen (24h):